• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种作为蛋白酪氨酸激酶抑制剂的抗肿瘤2-羟基亚芳基-4-环戊烯-1,3-二酮:TX-1123衍生物与Src激酶之间的相互作用

An Antitumor 2-Hydroxyarylidene-4-cyclopentene-1,3-Dione as a Protein Tyrosine Kinase Inhibitor: Interaction Between TX-1123 Derivatives and Src Kinase.

作者信息

Ohkura Kazuto, Kawaguchi Yuki, Tatematsu Yohei, Uto Yoshihiro, Hori Hitoshi

机构信息

Graduate School of Pharmaceutical Sciences, Suzuka University of Medical Science Graduate School, Suzuka, Japan

Faculty of Pharmaceutical Sciences, Chiba Institute of Science, Choshi, Japan.

出版信息

Anticancer Res. 2016 Jul;36(7):3645-9.

PMID:27354635
Abstract

BACKGROUND

Protein tyrosine kinases (PTKs) play major roles in signal transduction during cell proliferation and apoptosis. Tyrphostin AG17 was previously shown to be a potent tumor growth inhibitor, while AG17 induced apoptosis and inhibited activity of cyclin-dependent kinase 2. We herein describe the binding features of tyrphostin AG17 analogs, such as TX-1123, with Src kinase (Src-K).

MATERIALS AND METHODS

Structural data for Src-K were obtained from a protein data bank (ID=2SRC), and the molecular interactions between Src-K and TX-1123 derivatives were examined.

RESULTS

TX-1123 exihibited potent Src-K inhibitory activity (half maximal-inhibitory concentration=2.2 μM), and fit into the pocket of the Src-K molecule as well as c-AMP did.

CONCLUSION

The binding profiles of TX-1123 derivatives differed from each other, while their Src-K inhibitory activities were affected by their fit in the Src-K molecule.

摘要

背景

蛋白酪氨酸激酶(PTKs)在细胞增殖和凋亡过程中的信号转导中起主要作用。先前已证明 tyrphostin AG17 是一种有效的肿瘤生长抑制剂,而 AG17 可诱导细胞凋亡并抑制细胞周期蛋白依赖性激酶 2 的活性。我们在此描述 tyrphostin AG17 类似物(如 TX - 1123)与 Src 激酶(Src - K)的结合特征。

材料与方法

从蛋白质数据库(ID = 2SRC)获得 Src - K 的结构数据,并研究 Src - K 与 TX - 1123 衍生物之间的分子相互作用。

结果

TX - 1123 表现出强大的 Src - K 抑制活性(半数最大抑制浓度 = 2.2 μM),并且与 c - AMP 一样能很好地契合 Src - K 分子的口袋。

结论

TX - 1123 衍生物的结合模式彼此不同,而它们的 Src - K 抑制活性受其在 Src - K 分子中的契合情况影响。

相似文献

1
An Antitumor 2-Hydroxyarylidene-4-cyclopentene-1,3-Dione as a Protein Tyrosine Kinase Inhibitor: Interaction Between TX-1123 Derivatives and Src Kinase.一种作为蛋白酪氨酸激酶抑制剂的抗肿瘤2-羟基亚芳基-4-环戊烯-1,3-二酮:TX-1123衍生物与Src激酶之间的相互作用
Anticancer Res. 2016 Jul;36(7):3645-9.
2
TX-1123: an antitumor 2-hydroxyarylidene-4-cyclopentene-1,3-dione as a protein tyrosine kinase inhibitor having low mitochondrial toxicity.TX - 1123:一种作为蛋白酪氨酸激酶抑制剂的抗肿瘤2 - 羟基亚苄基 - 4 - 环戊烯 - 1,3 - 二酮,具有低线粒体毒性。
Bioorg Med Chem. 2002 Oct;10(10):3257-65. doi: 10.1016/s0968-0896(02)00160-8.
3
Design of hypoxia-targeting protein tyrosine kinase inhibitor using an innovative pharmacophore 2-methylene-4-cyclopentene-1,3-dione.使用创新药效团2-亚甲基-4-环戊烯-1,3-二酮设计靶向缺氧的蛋白酪氨酸激酶抑制剂
Biochim Biophys Acta. 2004 Mar 11;1697(1-2):29-38. doi: 10.1016/j.bbapap.2003.11.011.
4
Interactive Analysis of TX-1123 with Cyclo-oxygenase: Design of COX2 Selective TX Analogs.TX-1123与环氧化酶的相互作用分析:COX2选择性TX类似物的设计
Anticancer Res. 2017 Jul;37(7):3849-3854. doi: 10.21873/anticanres.11764.
5
PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.PH006 是一种新型、选择性Src 激酶抑制剂,能在体内外抑制人乳腺癌的生长和转移。
Breast Cancer Res Treat. 2011 Nov;130(1):85-96. doi: 10.1007/s10549-010-1302-4. Epub 2010 Dec 22.
6
Design, synthesis and evaluation of acridine derivatives as multi-target Src and MEK kinase inhibitors for anti-tumor treatment.吖啶衍生物作为多靶点Src和MEK激酶抑制剂用于抗肿瘤治疗的设计、合成与评价
Bioorg Med Chem. 2016 Jan 15;24(2):261-9. doi: 10.1016/j.bmc.2015.12.011. Epub 2015 Dec 8.
7
Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.一类新型强效选择性三取代嘌呤类化合物抑制Src酪氨酸激酶的结构基础
Chem Biol Drug Des. 2006 Jan;67(1):46-57. doi: 10.1111/j.1747-0285.2005.00316.x.
8
4-Aryl-4H-chromene-3-carbonitrile derivatives: evaluation of Src kinase inhibitory and anticancer activities.4-芳基-4H-色烯-3-甲腈衍生物:Src 激酶抑制和抗癌活性评价。
Med Chem. 2011 Sep;7(5):466-72. doi: 10.2174/157340611796799258.
9
Discovery of 4,6-substituted-(diaphenylamino)quinazolines as potent c-Src inhibitors.发现 4,6-取代-(二苯氨基)喹唑啉作为有效的 c-Src 抑制剂。
Org Biomol Chem. 2013 Dec 28;11(48):8375-86. doi: 10.1039/c3ob41161c. Epub 2013 Oct 31.
10
Discovery of novel purine derivatives with potent and selective inhibitory activity against c-Src tyrosine kinase.发现新型嘌呤衍生物,对 c-Src 酪氨酸激酶具有强效和选择性抑制活性。
Bioorg Med Chem. 2010 Jul 1;18(13):4615-24. doi: 10.1016/j.bmc.2010.05.032. Epub 2010 May 19.